 I. To assess the pharmacodynamic effects of anti-LAG-3 antibody BMS-986016, anti-CD137 antibody BMS- 663513, andor anti-PD-1 antibody BMS-936558 on biomarkers in peripheral blood, including the T cell compartments, and serum proteins cytokines and other immune modulators. 